Endo International plc Quarterly Goodwill in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Endo International plc quarterly Goodwill history and growth rate from Q4 2013 to Q4 2023.
  • Endo International plc Goodwill for the quarter ending December 31, 2023 was $1.35B, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.35B $0 0% Dec 31, 2023 10-K 2024-03-06
Q3 2023 $1.35B $0 0% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $1.35B -$97M -6.69% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.35B -$1.85B -57.7% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $1.35B -$1.85B -57.7% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $1.35B -$2.21B -62% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.45B -$2.11B -59.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.2B -$363M -10.2% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $3.2B -$363M -10.2% Dec 31, 2021 10-K 2024-03-06
Q3 2021 $3.56B $0 0% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $3.56B $0 0% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $3.56B $0 0% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $3.56B -$35.2M -0.98% Dec 31, 2020 10-K 2023-03-06
Q3 2020 $3.56B -$55.3M -1.53% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $3.56B -$55.7M -1.54% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $3.56B -$120M -3.26% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.6B -$169M -4.5% Dec 31, 2019 10-K 2022-03-01
Q3 2019 $3.62B -$441M -10.9% Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $3.62B -$439M -10.8% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $3.68B -$377M -9.29% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $3.76B -$685M -15.4% Dec 31, 2018 10-K 2021-02-26
Q3 2018 $4.06B -$394M -8.86% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $4.06B -$392M -8.82% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $4.06B -$593M -12.8% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $4.45B $0 0% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $4.45B -$2.96B -39.9% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $4.45B -$2.97B -40% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $4.65B -$2.77B -37.4% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $4.45B -$2.85B -39% Dec 31, 2016 10-K 2020-02-26
Q3 2016 $7.41B +$744M +11.2% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $7.42B +$4.37B +144% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $7.42B +$4.4B +145% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $7.3B +$4.4B +152% Dec 31, 2015 8-K 2018-05-08
Q3 2015 $6.67B +$2.86B +75.2% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $3.04B -$489M -13.8% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $3.03B -$498M -14.1% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $2.9B +$2.33B +412% Dec 31, 2014 10-K 2017-03-01
Q3 2014 $3.8B Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $3.53B Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $3.52B Mar 31, 2014 10-Q 2014-05-09
Q4 2013 $566M Dec 31, 2013 8-K 2015-06-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.